
The real test for Moderna's cancer vaccine isn't about beating Keytruda. It's keeping cancer from coming back in the long term.
来源:Market Watch发布于 2026-10-23
The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.
相关标的:MRNA
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。